{"id":121943,"date":"2025-10-14T18:28:26","date_gmt":"2025-10-14T18:28:26","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/121943\/"},"modified":"2025-10-14T18:28:26","modified_gmt":"2025-10-14T18:28:26","slug":"opus-genetics-to-participate-in-chardans-9th-annual","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/121943\/","title":{"rendered":"Opus Genetics to Participate in Chardan’s 9th Annual"},"content":{"rendered":"

RESEARCH TRIANGLE PARK, N.C., Oct. 14, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc.<\/a> (Nasdaq: IRD) (the \u201cCompany\u201d or \u201cOpus Genetics\u201d), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders, announced today that Ash Jayagopal, PhD, MBA, Chief Scientific and Development Officer, will present a corporate update at Chardan’s 9th Annual Genetic Medicines Conference on Tuesday, October 21, 2025, at 12:00 p.m. ET.<\/p>\n

A link to the live and archived webcast may be accessed on Opus Genetics\u2019 website under the Investors section: Events<\/a>.<\/p>\n

About Opus Genetics<\/strong><\/p>\n

Opus Genetics is a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders. The Company\u2019s pipeline features AAV-based gene therapies targeting inherited retinal diseases including Leber congenital amaurosis (LCA), bestrophinopathy, and retinitis pigmentosa. Its lead gene therapy candidates are OPGx-LCA5, which is in an ongoing Phase 1\/2 trial for LCA5-related mutations, and OPGx-BEST1, a gene therapy targeting BEST1-related retinal degeneration. Opus Genetics is also advancing Phentolamine Ophthalmic Solution 0.75%, a partnered therapy currently approved in one indication and being studied in two Phase 3 programs for presbyopia and reduced low light vision and nighttime visual disturbances. The Company is based in Research Triangle Park, NC. For more information, please visit www.opusgtx.com<\/a>.<\/p>\n

Contacts:<\/strong><\/p>\n

Investors<\/strong>
Jenny Kobin
Remy Bernarda
IR Advisory Solutions
ir@opusgtx.com<\/a><\/p>\n

Media<\/strong>
Kimberly Ha
KKH Advisors
917-291-5744
kimberly.ha@kkhadvisors.com<\/a><\/p>\n

Source: Opus Genetics, Inc.<\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"RESEARCH TRIANGLE PARK, N.C., Oct. 14, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD) (the \u201cCompany\u201d or…\n","protected":false},"author":2,"featured_media":121944,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[272],"tags":[18,458,19,1297,17,74292,74293,133],"class_list":{"0":"post-121943","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-eire","9":"tag-genetics","10":"tag-ie","11":"tag-inc","12":"tag-ireland","13":"tag-nasdaqird","14":"tag-opus-genetics","15":"tag-science"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/121943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=121943"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/121943\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/121944"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=121943"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=121943"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=121943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}